Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 5 studies | 26% ± 7% | |
neuron | 4 studies | 56% ± 19% | |
glial cell | 4 studies | 30% ± 21% | |
smooth muscle cell | 4 studies | 22% ± 4% | |
connective tissue cell | 3 studies | 28% ± 2% |
Insufficient scRNA-seq data for expression of HAND2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 98% | 3128.12 | 176 / 180 | 45% | 1.58 | 193 / 430 |
uterus | 99% | 5490.59 | 169 / 170 | 40% | 8.17 | 184 / 459 |
bladder | 100% | 2876.81 | 21 / 21 | 32% | 1.52 | 160 / 504 |
pancreas | 25% | 182.38 | 81 / 328 | 93% | 13.03 | 165 / 178 |
intestine | 84% | 7172.71 | 807 / 966 | 33% | 1.80 | 175 / 527 |
stomach | 47% | 4005.38 | 168 / 359 | 50% | 6.33 | 143 / 286 |
heart | 97% | 3288.04 | 832 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 2181.43 | 1288 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 64% | 3126.00 | 922 / 1445 | 28% | 1.21 | 52 / 183 |
liver | 58% | 465.87 | 132 / 226 | 33% | 1.54 | 134 / 406 |
adrenal gland | 24% | 638.19 | 62 / 258 | 66% | 267.78 | 152 / 230 |
breast | 40% | 420.92 | 185 / 459 | 37% | 0.83 | 417 / 1118 |
skin | 41% | 511.06 | 743 / 1809 | 18% | 1.36 | 86 / 472 |
adipose | 51% | 604.95 | 609 / 1204 | 0% | 0 | 0 / 0 |
thymus | 25% | 177.81 | 163 / 653 | 12% | 0.26 | 74 / 605 |
prostate | 24% | 186.84 | 59 / 245 | 6% | 0.32 | 29 / 502 |
brain | 0% | 1.68 | 7 / 2642 | 26% | 1.24 | 186 / 705 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.23 | 8 / 45 |
lung | 0% | 2.56 | 1 / 578 | 13% | 2.39 | 145 / 1155 |
spleen | 10% | 66.93 | 23 / 241 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.01 | 5 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042475 | Biological process | odontogenesis of dentin-containing tooth |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_2000679 | Biological process | positive regulation of transcription regulatory region DNA binding |
GO_0001525 | Biological process | angiogenesis |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0061325 | Biological process | cell proliferation involved in outflow tract morphogenesis |
GO_0003266 | Biological process | regulation of secondary heart field cardioblast proliferation |
GO_0061032 | Biological process | visceral serous pericardium development |
GO_0001701 | Biological process | in utero embryonic development |
GO_0048485 | Biological process | sympathetic nervous system development |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0007507 | Biological process | heart development |
GO_0001947 | Biological process | heart looping |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010613 | Biological process | positive regulation of cardiac muscle hypertrophy |
GO_0042421 | Biological process | norepinephrine biosynthetic process |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0003357 | Biological process | noradrenergic neuron differentiation |
GO_0061309 | Biological process | cardiac neural crest cell development involved in outflow tract morphogenesis |
GO_0043586 | Biological process | tongue development |
GO_1900745 | Biological process | positive regulation of p38MAPK cascade |
GO_0060536 | Biological process | cartilage morphogenesis |
GO_0048706 | Biological process | embryonic skeletal system development |
GO_0048935 | Biological process | peripheral nervous system neuron development |
GO_0007512 | Biological process | adult heart development |
GO_0048538 | Biological process | thymus development |
GO_0010463 | Biological process | mesenchymal cell proliferation |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0034103 | Biological process | regulation of tissue remodeling |
GO_1904036 | Biological process | negative regulation of epithelial cell apoptotic process |
GO_0003219 | Biological process | cardiac right ventricle formation |
GO_1904019 | Biological process | epithelial cell apoptotic process |
GO_0060982 | Biological process | coronary artery morphogenesis |
GO_2001262 | Biological process | positive regulation of semaphorin-plexin signaling pathway |
GO_0010667 | Biological process | negative regulation of cardiac muscle cell apoptotic process |
GO_0003278 | Biological process | apoptotic process involved in heart morphogenesis |
GO_0003253 | Biological process | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO_1903929 | Biological process | primary palate development |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0071407 | Biological process | cellular response to organic cyclic compound |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0001967 | Biological process | suckling behavior |
GO_0032991 | Cellular component | protein-containing complex |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0001223 | Molecular function | transcription coactivator binding |
GO_0003680 | Molecular function | minor groove of adenine-thymine-rich DNA binding |
GO_0070888 | Molecular function | E-box binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HAND2 |
Protein name | Heart- and neural crest derivatives-expressed protein 2 (Class A basic helix-loop-helix protein 26) (bHLHa26) (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND) HAND2 protein Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) |
Synonyms | BHLHA26 DHAND hCG_1743431 |
Description | FUNCTION: Essential for cardiac morphogenesis, particularly for the formation of the right ventricle and of the aortic arch arteries. Required for vascular development and regulation of angiogenesis, possibly through a VEGF signaling pathway. Also plays an important role in limb development, particularly in the establishment of anterior-posterior polarization, acting as an upstream regulator of sonic hedgehog (SHH) induction in the limb bud. Is involved in the development of branchial arches, which give rise to unique structures in the head and neck. Binds DNA on E-box consensus sequence 5'-CANNTG-3' (By similarity). . |
Accessions | H0YAH1 ENST00000359562.4 [P61296-1] Q32LY2 P61296 Q3T1D5 B3KV85 ENST00000503024.1 |